David A. Siegel Procept Bio Robotics Corp Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 54,800 shares of PRCT stock, worth $4.18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
54,800
Previous 93,400
41.33%
Holding current value
$4.18 Million
Previous $4.62 Million
27.48%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
214Shares Held
36.3MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$359 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$266 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$138 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$133 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$104 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.4B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...